The Potential For Nutrigenomics in Prevention of Metabolic Syndrome by Gangemi, J. David & King, Dana
The Potential For Nutrigenomics in Prevention of Metabolic Syndrome 
J. David Gangemi,a and Dana Kingb 
Department of Microbiology and Molecular Medicine, Clemson University, Clemson, SC 29634, USA, Fax: 1 864-656-3608; Tel: 1 864-656-3015; E-
mail: eaneemj(a),clemson. edu 
5 bFamily Care Medicine, Medical University of South Carolina, Charleston, SC 29412, USA, Tel: 1 843-792-5262; E-mail kinsde(a)musc. edu 
Received April 12, 2009 
The relationship between diet and health has been recognized for millennia, but precisely "how" diet interacts with human physiology to 
elicit health or disease is only now beginning to be understood. The sequencing of the human genome as well as the development of new 
and innovative technologies in systems biology has allowed scientists to ask more probing questions into the relationship between diet 
io and health at the most fundamental levels of biology. From this the "science of nutrigenomics" has emerged and it is now clear that 
certain dietary nutrients have the ability to interact with the human genome regulating gene function in positive and negative ways. Most 
importantly, the identification of specific nutrient chemicals that regulate genes is rapidly unfolding and the use of naturally occurring 
nutrient chemicals as pharmacological agents is becoming a reality. The net result is the development of new and innovative nutritional 
products for wellness and disease prevention. 
Introduction 
Dietary components provide the nutrient 
resources and energy needed for growth and repair of 
tissue throughout our lives. In adults, energy balance 
i or homeostasis occurs when energy intake equals 
energy expenditure. Maintenance of this balance is 
required for a stable body weight. A chronic positive 
energy balance results in excess fat and obesity, 
which is linked to a constellation of health maladies, 
and is referred to as "metabolic syndrome". This 
syndrome is associated with an increased risk of 
chronic diseases, including diabetes, cardiovascular 
disease, and stroke. Two hallmarks of metabolic 
syndrome are insulin resistance and increased 
i markers of chronic inflammation. 
Metabolic syndrome is characterized by a group 
of metabolic risk factors in a single person1. They 
include: 
• Central obesity (excessive fat tissue in and 
around the abdomen) 
• Atherogenic dyslipidemia (blood fat 
disorders — mainly high triglycerides and 
low HDL cholesterol — that foster plaque 
buildups in artery walls) 
• Insulin resistance or glucose intolerance (the 
body can't properly use insulin or blood 
sugar) 
• Prothrombotic state (e.g., high fibrinogen or 
plasminogen activator inhibitor in the blood) 
• Raised blood pressure (130/85 mmHg or 
higher) 
• Proinflammatory state (e.g., elevated high-
sensitivity C-reactive protein in the blood) 
The underlying causes of this syndrome are 
overweight/obesity, physical inactivity and genetic 
factors. People with the metabolic syndrome are at 
increased risk of coronary heart disease, other 
diseases related to plaque buildups in artery walls 
55 (e.g., stroke and peripheral vascular disease) and type 
2 diabetes. 
South Carolina has the dubious distinction of 
having one of the highest metabolic disease 
prevalence rates in the country2. The occurrence of 
so diseases related to this syndrome has resulted in a 
significant health-care burden and has prompted 
scientists from Clemson University, The University 
of SC and The Medical University of SC to join 
forces to seek solutions. In this regard an effort is 
65 now underway to form the SC Center of Economic 
Excellence in Molecular Nutrition where faculty from 
each university will collaborate to combine their 
individual strengths in plant breeding, nutrition, 
genomics, and gene regulation and function to 
70 develop prevention strategies. Motivation for this 
Center comes from long-held beliefs that chronic 
disease syndrome may one day be prevented through 
a better understanding and the mechanism through 
which specific nutrients are able to affect gene 
75 expression for human health. 
Molecular Nutrition and Wellness 
Molecular nutrition examines the interactions 
between nutrients and intracellular and extracellular 
molecules and is beginning to unravel the way 
so nutrients affect cellular processes. This emerging 
field has been identified as one of the most exciting 
new frontiers in biomedical technology with the 
potential to dramatically improve human health and 
wellness worldwide3. 
85 A component of molecular nutrition, 
nutrigenomics, or nutritional genomics, is a 
multidisciplinary science that combines information 
from genetics, nutrition, physiology, pathology, and 
molecular biology. The diet - nutrient interactions 
* which occur in different individuals is complex and 
scientists are focusing on the polymorphisms which 
affect these interactions to help alleviate health 
disparities. 
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Dietary chemicals have been shown to alter 
gene expression in a number of ways . For example, 
they may: 
act as ligands for transcription factor 
receptors 
be metabolized by primary or secondary 
metabolic pathways thereby altering 
concentrations of substrates or intermediates 
or 
alter signal transduction pathways 
genes not believed to be associated with nutrient 
utilization. While more complex than yeast, the 
constellation of genes that make up the human 
> genome respond in a similar fashion to dietary 
inputs5. 
The science of nutrigenomics is multifaceted, 
but primarily looks at the molecular relationships 
between dietary intake and the response of genes, 
i with the aim of extrapolating how gene expression 
affects human health3'4. Nutrigenomics focuses on of 
the molecular relationships between dietary intake the 
effect of diet on the genome, epigenome, proteome, 
and metabolome. In understanding these effects, 
> nutrigenomics attempts to define the relationship 
between specific nutrients and specific nutrient 
regimes (diets) on human health. Nutritional 
genomics, or nutrigenomics, is the study of how 
foods affect our genes and how individual genetic 
i differences can affect the way we respond to nutrients 
(and other naturally occurring compounds) in the 
foods we eat. 
While somewhat controversial, 
nutrigenomics has been popularized with the idea of 
> personalized nutrition based on genotype. While there 
is hope that nutrigenomics will ultimately enable such 
personalized dietary advice, the science is in its 
infancy and many more fundamental questions must 
be answered6. 
i Nutrigenomics and Disease Prevention 
Throughout the 20th century, nutritional science 
focused on finding vitamins and minerals, defining 
their use and preventing the deficiency diseases that 
they caused. As the nutrition-related health problems 
> of the developed world shifted to overnutrition, 
obesity and type 2 diabetes, the focus of modern 
medicine and of nutritional science changed 
accordingly. 
In order to address the increasing incidence 
i of these diet-related-diseases, the role of diet and 
nutrition has been and continues to be extensively 
studied. To prevent the development of disease, 
nutrition research is investigating how nutrition can 
optimize and maintain cellular, tissue, organ and 
55 whole body homeostasis. This requires understanding 
how nutrients act at the gene, protein and metabolic 
levels. As a result, nutrition research has shifted from 
epidemiology and physiology to molecular biology 















With this paradigm shift new data has 
emerged in support of dietary interventions in 
preventing, mitigating, or treating chronic disease, 
and certain cancers. The conceptual basis and 
scientific evidence to support dietary interventions 
i can be found in the following observations: 
• Under certain circumstances and in some 
individuals, diet can be a serious risk factor 
for a number of diseases. 
• Common dietary chemicals can act on the 
i human genome, either directly or indirectly, 
to alter gene expression or structure. 
• The degree to which diet influences the 
balance between healthy and disease states 
may depend on an individual's genetic 
i makeup. 
• Some diet-regulated genes (and their normal, 
common variants) are likely to play a role in 
the onset, incidence, progression, and/or 
severity of chronic diseases. 
i • Dietary intervention based on knowledge of 
nutritional requirement, nutritional status, 
and genotype, have been used to prevent, 
mitigate or cure chronic disease. 
The emergence and development of 
i nutrigenomics has been possible due to powerful 
developments in genetic research. With these 
developments, biochemical disorders with a high 
nutritional relevance have been linked to a genetic 
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origin. Such disorders include a polymorphism in the 
gene for the hormone Leptin which results in gross 
obesity. While a few other genetic polymorphisms 
have been described, it is thought that many others 
result in minor deviations in nutritional biochemistry. 
The tools to study the physiological impact of these 
genetic polymorphisms are only now becoming 
available. Such tools include those that measure the 
transcriptome - DNA microarray, exon array, single 
i nucleotide polymorphism arrays and genotyping5'6. 
The Promise of Nutrigenomics 
In nutrigenomics, nutrients are seen as 
signals that communicate with specific cells in the 
body. These nutrients may be detected by a sensory 
system much like those associated with toll-like 
receptors on cell surfaces. Like the toll receptor, 
cellular signaling is induced through transcription 
factors which alter gene expression and 
protein/metabolite production in accordance with the 
i level of nutrient present in the cell environment. As a 
result, it is believed that different diets will elicit 
different patterns of gene and protein expression and 
metabolite production. Nutrigenomics seeks to 
describe the patterns of these effects which have been 
referred to as dietary signatures6. Such dietary 
signatures can be examined in specific cells, tissues 
and organisms and in this way the manner by which 
nutrition influences homeostasis can be better 
understood. Genes which are affected by differing 
i levels of nutrients are now being identified and their 
regulatory pathways are under investigation3. 
Through the identification of these genes and their 
regulatory pathways, scientists will soon have a better 
understanding of how nutrition influences metabolic 
pathways and homeostasis, Such an understanding 
will be essential in attempts to prevent the 
development of chronic diet related diseases such as 
obesity and type 2 diabetes. In this regard, finding 
markers of the early phase of diet related diseases for 
i intervention with selected nutrients that could reverse 
or slow the disease process will expand the 
application of nutrigenomics. Thus, once a marker 
has been found and measured, the extent to which an 
individual is susceptible to disease development may 
be quantified and personalized dietary 
recommendations prescribed. Progress in this area 
will lead to the marketing and distribution of 
"science-based functional foods" that will keep 
people healthy according to their individual needs. 
i Chronic Disease Syndrome in SC 
An estimated 79 million American adults (1 
in 3) have cardiovascular disease (CVD), and 
millions more are at risk due to the presence of 
obesity, hypertension, and hyperlipidemia1 CVD 
i accounts for 36.3% of U.S. mortality, or 1 out of 
every 2.8 deaths. SC is a leader in heart disease and 
in stroke among the U.S states; heart disease is the 
leading cause of death in SC, accounting for 10,000 
deaths annually.2 Further, in 2007, SC had the 
i seventh worst obesity rate in the nation, with over 
65% of all SC adults either overweight or obese. 
When examined across race/ethnicity in SC adults, a 
larger proportion of African-Americans in the state 
are overweight or obese (73.6%) as compared to 
i Whites (63%)7 Recent research has established that 
inflammation plays a key role in the atherosclerotic 
process8'9. Endothelial injury and plaque rupture are 
inflammatory processes that lead to thrombosis, 
myocardial infarction and stroke. Several proteins 
.participate in the inflammatory processes that are 
useful for measurement. The most common and 
clinically useful measure is highly sensitive C-
reactive protein (hsCRP), but several other markers 
have been investigated9'1 . 
i A pharmaceutical approach to prevention of 
CVD inherently exposes millions of people without 
disease to the risk of adverse effects and interactions 
of multiple medications (aspirin—ulcers, bleeding; 
statins—liver dysfunction/myopathy; fenfluramine 
i and phentermine—valvular heart disease and 
pulmonary hypertension). A more appealing 
approach is to identify, test, and use natural 
phytochemicals with anti-inflammatory and 
antioxidant activity and few side effects, to not only 
; prevent CVD but promote general wellbeing. 
Dietary Interventions to Reduce Chronic Disease 
Syndrome in SC 
One of the most promising candidates 
currently under investigation in South Carolina is the 
> common table grape. Animal, laboratory, and 
epidemiologic data indicate that higher intake of 
polyphenol-rich grapes have anti-inflammatory and 
potent antioxidant effects that may reduce the risk of 
CVD and other chronic disease states such as 
i hypertension. These beneficial effects have been 
attributed to the bioactive constituents resveratrol and 
flavonoids such as anthocyanins1112. Recent evidence 
shows that red wine derived from table grapes (Vitis 
vinifera) may lower the risk of CVD1 ~15. Before 
i proceeding with clinical studies of grape concentrates 
in clinical populations, the potential bioactive 
phytochemicals in grapes need to be more fully 
identified. The molecular mechanisms underlying the 
effect of grape phytochemicals in CVD prevention 
i are yet to be elucidated, but alterations in cell 
signaling pathways leading to inflammation are a 
distinct possibility. Phase I and II trials need to be 
conducted in a carefully chosen target population 
with increased inflammation and oxidative stress 
i (overweight/obese but otherwise healthy adults,16"18 to 
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determine the maximum tolerable dose, adverse 
effects and effective dose ranges of grape products. 
In contrast to table grapes, research on 
muscadine (Vitis rotundifolia), a native and valuable 
• fruit crop in Southeastern US, including SC and GA, 
is under-developed. Muscadine is classified under the 
genus Vitis with other grape species, but further 
classified to a separate subgenus, Muscadinia, due to 
genetic and botanical differences between muscadine 
i and other grapes. Muscadines are well adapted to 
warm and humid climate in the Southeastern US in 
which other grapes do not thrive. Muscadines have a 
higher total phenolic content compared to table 
grapes and small fruits 19. Recent evidence shows 
• that photochemical constituents of muscadines are 
distinct and differ from other grapes by having 
unique phenolic compounds, such as ellagic acid and 
other anthocyanins in appreciable amounts20"22. 
Anthocyanins are present as 3,5-diglucosides in the 
i muscadine as opposed to 3-glucosides in other 
grapes, and glycosylation has been shown to be a 
major determinant of bioavailability 22,23 Major 
phenolics reported in muscadine skins are ellagic 
acid, myricetin, quercetin, and kaempferol while for 
• the muscadine seeds are gallic acid, catechin, and 
epicatechin20; most of the polyphenols are 
concentrated in the seed and skin. Therefore, 
muscadine seed and skin polyphenols may have 
different bioactivity, as compared to those of other 
i grapes, due to the presence of unique polyphenols. 
These unique constituents may act as a source of 
novel compounds for targeted intervention in the 
inflammatory pathways. Clinical studies now 
underway at the Medical University of SC will focus 
• on chemically defined constituents from muscadine 
seed and skin extracts to determine which ones have 
the greatest impact on inflammatory markers in 
patients with metabolic syndrome. Once identified, 
these extracts will be evaluated in larger trials in and 
i out of SC to evaluate the long-term effects on 
prevention and/or delay in onset of the diseases 
associated with metabolic syndrome. 
While it appears that certain classes of 
polyphenols, e.g. anthocyanins, in muscadines 
• contain the bioactives needed for reducing 
inflammation, the cellular mechanism by which these 
substances impact disease are complex involving a 
highly evolved cellular circuitry in which gene 
expression, either directly or indirectly induced, 
iresults in physiologic change. With the recent 
advancements in systems biology (genomics, 
proteomics, and metabolomics) we may soon be able 
to dissect and control cellular circuits, which are 
regulated by polyphenols. Certainly our ability to 
• control expression of nuclear factor-kappaB and 
inflammatory cytokines such as TNF-alpha and 11-6 
appear to be likely candidates for initial 
investigations. 
Conclusions 
i The science of nutrigenomics continue to generate 
much interest and activity with the expectation that 
many of the disparities in wellness can be prevented, 
but much remains to be done, and this science is still 
in its infancy. The promise of nutritional genomics in 
i personalized medicine and health is based on an 
understanding of our nutritional needs, nutritional and 
health status, and our genotype. Nutrigenomics could 
have significant impacts on society - from medicine 
to agricultural and dietary practices to social and 
.public policies - and its applications are likely to 
compare to those arising from the human genome 
project. Chronic diseases (and some types of cancer) 
may be preventable, or at least delayed, by balanced, 
sensible diets. Knowledge gained from comparing 
i diet/gene interactions in different populations may 
provide information needed to address the larger 
problem of global malnutrition and disease. 
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